MedTrace Logo

A Double-blind, Randomized, Controlled Trial of Quetiapine Versus Haloperidol for the Treatment of Delirium

NCT00954603 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2011-06-23

No results posted yet for this study

Summary

The purpose of this study is to determine whether quetiapine, and haloperidol are effective and safe in the treatment psychiatric symptoms in patients with delirium.

Conditions

  • Delirium

Interventions

DRUG

quetiapine

25-100 mg

DRUG

haloperidol

0.5-2 mg

Sponsors & Collaborators

  • Chiang Mai University

    lead OTHER

Principal Investigators

  • Benchalak Maneeton, Assoc Prof · Department of Psychiatry,Faculty of Medicine, Chiang Mai university, Thailand

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2011-04-30
Completion
2012-07-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00954603 on ClinicalTrials.gov